Medartis Holding Ag Stock Net Income
| MDRSF Stock | USD 100.00 2.01 1.97% |
Fundamental analysis of Medartis Holding allows traders to better anticipate movements in Medartis Holding's stock price by examining its financial health and performance throughout various phases of its business cycle.
Medartis |
Medartis Holding AG Company Net Income Analysis
Medartis Holding's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Medartis Holding Net Income | 6.84 M |
Most of Medartis Holding's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medartis Holding AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Medartis Holding AG reported net income of 6.84 M. This is much higher than that of the sector and significantly higher than that of the Medical Devices industry. The net income for all United States stocks is notably lower than that of the firm.
Medartis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medartis Holding's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medartis Holding could also be used in its relative valuation, which is a method of valuing Medartis Holding by comparing valuation metrics of similar companies.Medartis Holding is currently under evaluation in net income category among its peers.
Medartis Fundamentals
| Return On Equity | -0.001 | |||
| Return On Asset | 0.0165 | |||
| Profit Margin | (0) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 1.08 B | |||
| Shares Outstanding | 11.86 M | |||
| Shares Owned By Insiders | 67.81 % | |||
| Shares Owned By Institutions | 11.78 % | |||
| Price To Book | 2.95 X | |||
| Price To Sales | 6.68 X | |||
| Revenue | 159.88 M | |||
| Gross Profit | 134.11 M | |||
| EBITDA | 25.43 M | |||
| Net Income | 6.84 M | |||
| Book Value Per Share | 20.54 X | |||
| Cash Flow From Operations | 20.99 M | |||
| Earnings Per Share | 0.60 X | |||
| Number Of Employees | 832 | |||
| Beta | 0.97 | |||
| Market Capitalization | 1.16 B | |||
| Total Asset | 298.18 M | |||
| Net Asset | 298.18 M |
About Medartis Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medartis Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medartis Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medartis Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Medartis Pink Sheet
Medartis Holding financial ratios help investors to determine whether Medartis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medartis with respect to the benefits of owning Medartis Holding security.